Plisson Christophe, McConathy Jonathan, Martarello Laurent, Malveaux Eugene J, Camp Vernon M, Williams Larry, Votaw John R, Goodman Mark M
Department of Radiology, Emory University, Atlanta, Georgia 30320, USA.
J Med Chem. 2004 Feb 26;47(5):1122-35. doi: 10.1021/jm030384e.
2beta-Carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]tropane (ZIET) and 2beta-carbomethoxy-3beta-[4'-((Z)-2-bromoethenyl)phenyl]tropane (ZBrET) were synthesized as well as their nortropane congeners ZIENT and ZBrENT. Binding affinities of these compounds were determined in cells transfected to express human SERT, DAT, and NET using [3H]citalopram, [125I]RTI-55, and [3H]nisoxetine, respectively. Both ZIET and ZBrET displayed high affinity for the SERT (Ki = 0.11 and 0.08 nM, respectively). The affinities of ZIET and ZBrET for the DAT were 200 and 38-fold lower, respectively, than for the SERT. [11C]ZIET and [11C]ZBrET were prepared by alkylation of their corresponding nortropanes with [11C]methyl iodide in approximately 30% radiochemical yield (decay-corrected to end of bombardment, EOB). High specific activity [123I]ZIET was synthesized in 33% radiochemical yield (decay-corrected) by treating the 2beta-carbomethoxy-3beta-[4'-((Z)-2-trimethylstannylethenyl)phenyl]tropane (3) with no carrier-added sodium [123I]iodide and hydrogen peroxide in ethanolic HCl. Biodistribution studies in rats indicated that [123I]ZIET enters the brain readily and accumulates in SERT-rich regions. Blocking studies performed in rats demonstrated that [123I]ZIET was selective and specific for SERT-rich regions (e.g. thalamus, brainstem, and striatum). MicroPET brain imaging studies in monkeys demonstrated that [11C]ZIET and [11C]ZBrET uptakes were selectivity localized in the putamen, midbrain, caudate, thalamus, pons, and medulla. Radioactivity in the regions of high SERT density of monkey brain was displaceable with citalopram except in the putamen and caudate. Radioactivity uptake in these DAT-rich regions was significantly displaceable either by preadministration of citalopram followed by injection of RTI-113 (or vice-versa) or by administration of a mixture of DAT and SERT ligands. In conclusion, the high yield, high specific activity, one-step radiolabeling method, high selectivity and favorable kinetics, and the good results obtained with [123I]ZIET in rats support the candidacy of [11C]ZIET for in vivo visualization and quantification of brain SERT.
合成了2β-甲氧羰基-3β-[4'-((Z)-2-碘乙烯基)phenyl]托烷(ZIET)和2β-甲氧羰基-3β-[4'-((Z)-2-溴乙烯基)phenyl]托烷(ZBrET)及其去甲托烷类似物ZIENT和ZBrENT。分别使用[3H]西酞普兰、[125I]RTI-55和[3H]去甲替林,在转染以表达人5-羟色胺转运体(SERT)、多巴胺转运体(DAT)和去甲肾上腺素转运体(NET)的细胞中测定了这些化合物的结合亲和力。ZIET和ZBrET对SERT均表现出高亲和力(Ki分别为0.11和0.08 nM)。ZIET和ZBrET对DAT的亲和力分别比对SERT低200倍和38倍。[11C]ZIET和[11C]ZBrET通过用[11C]碘甲烷烷基化它们相应的去甲托烷制备,放射化学产率约为30%(衰变校正至轰击结束,EOB)。通过在乙醇盐酸中用无载体添加的[123I]碘化钠和过氧化氢处理2β-甲氧羰基-3β-[4'-((Z)-2-三甲基锡乙烯基)phenyl]托烷(3),以33%的放射化学产率(衰变校正)合成了高比活度的[123I]ZIET。大鼠体内生物分布研究表明,[123I]ZIET很容易进入脑内并在富含SERT的区域蓄积。在大鼠中进行的阻断研究表明,[123I]ZIET对富含SERT的区域(如丘脑、脑干和纹状体)具有选择性和特异性。猴子的微型正电子发射断层脑成像研究表明,[11C]ZIET和[11C]ZBrET的摄取选择性地定位于壳核、中脑、尾状核、丘脑、脑桥和延髓。除壳核和尾状核外,西酞普兰可置换猴脑高SERT密度区域的放射性。预先给予西酞普兰后注射RTI-113(或反之)或给予DAT和SERT配体混合物,均可显著置换这些富含DAT区域的放射性摄取。总之,高产率、高比活度、一步放射性标记方法、高选择性和良好的动力学,以及[123I]ZIET在大鼠中获得的良好结果,支持[11C]ZIET作为体内可视化和定量脑SERT的候选药物。